Evidence map›Paper›PMID 38164147›Full record

ArticleTheranostics2024

Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs).

Richard P Baum, Peipei Wang, Vivianne Jakobsson, Tianzhi Zhao, Christiane Schuchardt, Pek-Lan Khong, Jingjing Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Synthesis, preclinical evaluation, and clinical translation of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Richard P BaumCURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany.
Peipei WangDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Vivianne JakobssonDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Tianzhi ZhaoDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Christiane SchuchardtTheranostics Center for Molecular Radiotherapy and Precision Oncology, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.
Pek-Lan KhongDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Jingjing ZhangDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
National University of Singapore · SGZentralklinik Bad Berka · DE

Funding

Society for Epidemiologic Research Doctoral Dissertation WorkshopR13TR002021 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HARLOW, BERNARD L · 2017 to 2018
$46k
National Medical Research Counci CS-IRG NIG GRANT (MOH-001254-01National University of Singapore NUHSRO/2021/097/STARTUP/13; NUHSRO/2020/133/STARTUP/08NMRC Centre Grant Programme CG21APR1005NUS School of Medicine Nanomedicine Translational Research Programme NUHSRO/2021/034/TRP/09/NANOMEDICINENUS Theranostics Center of Excellence NUHSRO/2023/008/NUSMED/TCE/LOA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neoplasms, Unknown PrimaryNeuroendocrine TumorsOrganometallic CompoundsFemaleHumansMaleOctreotidePositron Emission Tomography Computed TomographyRadioisotopesReceptors, SomatostatinRetrospective StudiesOctreotideOrganometallic CompoundsRadioisotopesReceptors, Somatostatin177Lu90YefficacyNETs of unknown primary site (CUP-NETs)peptide receptor radionuclide therapy (PRRT)somatostatin receptor (SSTR)

Identifiers

PMID38164147
PMCPMC10750196
OpenAlexW4388699900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.